8 key surgeon Q&As on biologics in orthopedics & spine

Written by Shayna Korol | June 07, 2018 | Print  |

Here are eight Q&As on the application of biologics in orthopedics and spine.

1. Four spine surgeons discussed trends in the use of spine biologics.

2. Mick Perez-Cruet, MD, detailed where the spine field is headed.

3. Former North American Spine Society President William Watters, MD, of Houston Medical, described the biggest spine technology, clinical and business trends for 2018.

4. Roger Hartl, MD, director of spinal surgery and neurotrauma at Weill Cornell Brain and Spine Center in New York City and director of the Weill Cornell Medicine Center for Comprehensive Spine Care, offered two key thoughts on where spine surgery is headed in the future, including technology and practice trends.

5. Michael Gordon, MD, a spine surgeon with Hoag Orthopedic Institute in Irvine, Calif., weighed in on trends he sees with regard to the use of spinal biologics.

6. Three spine surgeons from across the U.S. discussed where they see the biggest opportunities in spinal biologics and disc generation.

7. Luga Podesta, MD, spoke about the possibilities and pitfalls of stem cell therapies in orthopedics and trends in regenerative medicine.

8. PolarityTE Executive Vice President, COO and Director Ned Swanson, MD, spoke about how the orthopedic and spine specialties could benefit from the company's bone and skin regeneration products and other technologies in development.

More articles on biologics:

International Stem Cell Corp. to launch joint supplement for osteoarthritis pain in Q3 2018

How Dr. Kevin Stone helped Super Bowl champion Tracy Porter make a comeback — 6 details

Study: First-in-human neural stem cell transplantation shows promise for spinal cord injury treatment — 5 takeaways

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months